Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial

This phase III clinical trial was conducted to evaluate the immunogenicity and safety of the single-dose and multi-dose formulations of a novel MMR vaccine (live, freeze-dried) developed by M/s Cadila Healthcare Limited, India (Cadila MMR vaccine), containing the Hoshino mumps strain, compared to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sood, Ashwani, Mitra, Monjori, Joshi, Himanshu Arvind, Nayak, Uma Siddhartha, Siddaiah, Prashanth, Babu, T. Ramesh, Mahapatro, Samarendra, Sanmukhani, Jayesh, Gupta, Gaurav, Mittal, Ravindra, Glueck, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512778/
https://www.ncbi.nlm.nih.gov/pubmed/28362563
http://dx.doi.org/10.1080/21645515.2017.1302629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512778/
https://www.ncbi.nlm.nih.gov/pubmed/28362563
http://dx.doi.org/10.1080/21645515.2017.1302629

Ejemplares similares